好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Poster Session 07

Thursday 04/26/12
02:00 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Epilepsy, Ethics, Pain and Palliative Care, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neurologic 好色先生, Neurotoxicology
No CME available

Program Evaluations

Event Timeline
02:00 PM - 06:30 PM Abstract 001 - Prevalence of Stroke and Transient Ischemic Attack in the Setting of Inflammatory Bowel Disease: A Retrospective Review
02:00 PM - 06:30 PM Abstract 002 - Attitudes of Neurologists and Nurses towards Prognosis and Quality of Life after Decompressive Hemicraniectomy after Space-Occupying MCA Infarction
02:00 PM - 06:30 PM Abstract 003 - Simplified Symptoms-Based Score for the Assessment of Ischemic Stroke Severity
02:00 PM - 06:30 PM Abstract 004 - Immunotherapy for Stroke: A New Hope of Treatment
02:00 PM - 06:30 PM Abstract 005 - Abciximab after IV rt-PA for Fluctuating Lacunar Syndrome
02:00 PM - 06:30 PM Abstract 006 - Transfer to Tertiary Care Hospitals Improve Outcome in Patients with Subarachnoid Hemorrhage but Not Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 007 - Vulnerability to Contralateral Pneumonia in Patients with Hemispheric Strokes
02:00 PM - 06:30 PM Abstract 008 - An Analysis of Institutional Events Preceding tPA for Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 009 - Cerebral Venous Thrombosis: Descriptive Study of a Hospital Series
02:00 PM - 06:30 PM Abstract 010 - Stroke Awareness in the Saudi Arabia Community: Prompt Public Health Measures Must Be Implement
02:00 PM - 06:30 PM Abstract 011 - Occurrence and Prognostic Significance of Pseudodissection Phenomenon Associated with Acute Distal Internal Carotid Artery Occlusion
02:00 PM - 06:30 PM Abstract 012 - Homozygous Methylenetetrahydrofolate Reductase Mutation Causing Saddle Aortic Arch Embolus with Right Middle Cerebral Artery Infarct
02:00 PM - 06:30 PM Abstract 013 - Cerebral Venous Thrombosis and Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Study on Twelve Cases
02:00 PM - 06:30 PM Abstract 014 - Discharge Destination as a Surrogate for Modified Rankin Scale Defined Outcomes at 3 and 12 Months among Stroke Survivors
02:00 PM - 06:30 PM Abstract 015 - Variables That Best Differentiate Acute Stroke from Stroke Mimics in Inpatients with Acute Neurological Deficits
02:00 PM - 06:30 PM Abstract 016 - A Tertiary Care Center's Experience with Central Nervous System Vasculitis (CNSV)
02:00 PM - 06:30 PM Abstract 017 - A New Classification Scheme for Spinal Vascular Abnormalities Based on Angiographic Features
02:00 PM - 06:30 PM Abstract 018 - Stroke Code Patients Are More Likely To Arrive at the Hospital by Ambulance on Weekends vs. Weekdays
02:00 PM - 06:30 PM Abstract 019 - Seeing Double: Intercavernous Sinus Dural Arteriovenous Fistula as a Rare Cause of Bilateral Abducens Palsy
02:00 PM - 06:30 PM Abstract 020 - The Interplay between the Electrocardiogram (ECG) QT Interval Dispersion and Acute Stroke: A Systematic Review
02:00 PM - 06:30 PM Abstract 021 - Susac Syndrome: Clinical Characteristics and Treatment in 29 New Cases
02:00 PM - 06:30 PM Abstract 022 - Utility of a Physician Directed, Nurse Based Stroke Prevention Program
02:00 PM - 06:30 PM Abstract 023 - Multi-Modal CT Delays Initiation of Intravenous rt-PA for Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 024 - International Normalized Ratio and In-Hospital Mortality of Subdural Hematoma
02:00 PM - 06:30 PM Abstract 025 - Erectile Dysfunction (ED) after Ischemic Stroke - Association between Prevalence and Localization of Lesion
02:00 PM - 06:30 PM Abstract 026 - New Onset Atrial Fibrillation. Changing the Pathophysiological Paradigm: Neurogenic Origin in Younger Patients with a Healthy Heart?
02:00 PM - 06:30 PM Abstract 027 - Non-Hospitalized Stroke: Patient's Underestimation or Doctor's Misdiagnosis?
02:00 PM - 06:30 PM Abstract 028 - Cerebral Venous Thrombosis: The Problem of Timely Diagnosis and Treatment
02:00 PM - 06:30 PM Abstract 030 - Cost-Effectiveness of Intracranial Stent Placement Versus Optimal Medical Management in Patients with Symptomatic Intracranial Stenosis
02:00 PM - 06:30 PM Abstract 031 - Cocaine Use and the Likelihood of Cardiovascular and All-Cause Mortality: Data from the Third National Health and Nutrition Examination Survey Mortality Follow-Up Study
02:00 PM - 06:30 PM Abstract 032 - The Relationship between Acute Stress Hyperglycemia and Infarct Volume in Ischemic Stroke
02:00 PM - 06:30 PM Abstract 033 - The Presence of Intracranial Vascular Calcification May Protect Against Vasospasm Following Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 035 - Role of Mean Transit Time (MTT) Perfusion Map on the Aquilion ONE CT Scanner Using SVD+ Algorithm in Acute Stroke
02:00 PM - 06:30 PM Abstract 036 - The Incidence and Predictors of Acute Infarction in Patients with Transient Ischemic Attack Using Magnetic Resonance Imaging Including Diffusion-Weighted Imaging. QugSS2-Registry
02:00 PM - 06:30 PM Abstract 037 - Microembolus Detection by Transcranial Doppler Ultrasound Monitoring
02:00 PM - 06:30 PM Abstract 038 - High Resolution Imaging of Brain Vessels at 7 Tesla
02:00 PM - 06:30 PM Abstract 039 - Correlations between Both MRS and DTI with Cognitive Function in Patients with Diabetes Mellitus
02:00 PM - 06:30 PM Abstract 040 - Prognostic Utility of Immediate Post-Procedural Head Computed Tomographic Scan after Endovascular Treatment of Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 041 - Clinical and Radiologic Spectrum of Corpus Callosum Infarctions: A Case Series
02:00 PM - 06:30 PM Abstract 042 - Primary Angiitis of the Central Nervous System Presenting with Microhemorrhages on Gradient Echo Imaging
02:00 PM - 06:30 PM Abstract 043 - Predictive Factors for the Recurrence of Noncardioembolic Ischemic Stroke Associated with Antiplatelet Failure
02:00 PM - 06:30 PM Abstract 044 - High Intake of Caffeine Use in Protective in Survivors of Stroke and Myocardial Infarction: The Results of Third National Health and Nutrition Examination Survey Mortality Follow-Up Study
02:00 PM - 06:30 PM Abstract 045 - Unchanging Incidence of Ischemic Stroke in Patients with Sickle Cell Disease in the Post STOP I and II Era
02:00 PM - 06:30 PM Abstract 046 - Early Access to a Neurologist Reduces the Rate of Stroke Misdiagnosis in Young Adults
02:00 PM - 06:30 PM Abstract 047 - A Pilot Population-Based Outcomes Study Using a Health Information Exchange (HIE): Demographic Comparison of Groups
02:00 PM - 06:30 PM Abstract 048 - Persistent Depression after Acute Stroke Predicts Dementia
02:00 PM - 06:30 PM Abstract 049 - Potential Synergy between Advanced Primary Stroke Centers and Level I or II Trauma Centers in United States
02:00 PM - 06:30 PM Abstract 050 - Stroke Risk Factors and Ischemic Subtypes in a Multiethnic Population in Central and East Brooklyn
02:00 PM - 06:30 PM Abstract 051 - Sources of Knowledge for Stroke Warning Signs and Risk Factors within a Population
02:00 PM - 06:30 PM Abstract 052 - Vitamin D Intake: A Novel Neuroprotectant?
02:00 PM - 06:30 PM Abstract 053 - Natalizumab-Associated Progressive Multifocal Leucoencephalopathy: Lessons from Four Different Cases
02:00 PM - 06:30 PM Abstract 054 - Assessment and Concordance of Serum Anti JC Virus Antibodies and JCV DNA Presence in Multiple Sclerosis Natalizumab Treated Patients
02:00 PM - 06:30 PM Abstract 055 - Inflammatory Variant of Progressive Multifocal Leukoencephalopathy; in a Patient with Early Systemic Lupus Erythrematosus
02:00 PM - 06:30 PM Abstract 056 - Accurate Risk Assessment for the Development of PML in Natalizumab Treated MS Patients Requires CSF Analysis
02:00 PM - 06:30 PM Abstract 057 - PML MRI Patterns in MS Patients Treated with Natalizumab: An Update of Natalizumab PML-MRI Guidelines
02:00 PM - 06:30 PM Abstract 058 - Classification of Natalizumab Cases with Progressive Multifocal Leukoencephalopathy
02:00 PM - 06:30 PM Abstract 059 - Subtle Lesion Appearance on MRI May Precede Development of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab
02:00 PM - 06:30 PM Abstract 060 - Successful Treatment of Natalizumab Induced PML with CMX001 and the Side Effects Associated with Its Use
02:00 PM - 06:30 PM Abstract 061 - MRI and DTI Characteristics of Natalizumab Associated PML during a Novel Treatment Protocol
02:00 PM - 06:30 PM Abstract 062 - Novel Interventions with Favorable Resolution of Natalizumab-Induced Progressive Multifocal Leukoencephalopathy (PML)
02:00 PM - 06:30 PM Abstract 063 - A Mother-Daughter Pair with Neuromyelitis Optica Spectrum Disorder
02:00 PM - 06:30 PM Abstract 064 - Syndrome of Inappropriate Antidiuresis May Herald or Accompany Neuromyelitis Optica
02:00 PM - 06:30 PM Abstract 065 - Olfactory Dysfunction in Different Subtypes of Multiple Sclerosis and in Neuromyelitis Optica
02:00 PM - 06:30 PM Abstract 066 - Periependymal Abnormalities in Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Case-Control Study
02:00 PM - 06:30 PM Abstract 067 - Neuromyelitis Optica Experience in an Argentinian Neuroimmunology Clinic
02:00 PM - 06:30 PM Abstract 068 - Prevalence of Serum Anti-Aquaporin4 Antibodies in Patients with HTLV-1 Associated Myelopathy Compared to Neuromyelitis Optica and NMO Spectrum Disorders in a Brazilian Tertiary Hospital. Preliminary Results
02:00 PM - 06:30 PM Abstract 069 - Systemic Autoantibodies in Neuromyelitis Optica: Is There Any Impact on Clinical Outcome?
02:00 PM - 06:30 PM Abstract 070 - Pain in Neuromyelitis Optica Is More Common, Disabling, and Refractory Compared to MS
02:00 PM - 06:30 PM Abstract 071 - Ethnic Disparities in Outcomes and Resource Utilization in Neuromyelitis Optica Related Hospitalizations
02:00 PM - 06:30 PM Abstract 072 - Clinical Description of Patients with the Neuromyelitis Optica Spectrum in a Tertiary Referral Center of Mexico
02:00 PM - 06:30 PM Abstract 073 - Natural History of MS Symptoms: Perceived Disease Impact across Disease Span in Nine Neurologic Domains among Enrollees in North American Research Committee on Multiple Sclerosis (NARCOMS) Registry
02:00 PM - 06:30 PM Abstract 074 - A Prospective Study of Spasticity in Individuals with Multiple Sclerosis (MS) in Transition from Interferon-Beta to Glatiramer Acetate
02:00 PM - 06:30 PM Abstract 075 - High Frequency and Adverse Impact of Vertigo and Dizziness in Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 076 - Do Cerebellar Symptoms Predict Treatment Response to Prolonged-Release Fampridine in Multiple Sclerosis Patients?
02:00 PM - 06:30 PM Abstract 077 - Prevalence and Etiology of Sleep Disorders and Alertness in Multiple Sclerosis with Assessing the Impact on Quality of Life
02:00 PM - 06:30 PM Abstract 078 - Relationship between Heat Intolerance and Response to Prolonged-Release Fampridine in Patients with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 079 - Response to Prolonged-Release Fampridine in Multiple Sclerosis Patients with Various Walking-Related MS Symptoms
02:00 PM - 06:30 PM Abstract 080 - People with Multiple Sclerosis Show Improved Gait with Balance-Based Torso Weighting
02:00 PM - 06:30 PM Abstract 081 - Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial
02:00 PM - 06:30 PM Abstract 082 - Impact of Relapses with Sequelae on Disability, Health-Related Quality of Life, and Fatigue in a Population with Relapsing Forms of Multiple Sclerosis Using Data from TEMSO, a Pivotal Phase III Teriflunomide Trial
02:00 PM - 06:30 PM Abstract 083 - Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 084 - Beneficial Effect of IgG Glycan Hydrolysis by EndoS in Central Nervous System Autoimmunity
02:00 PM - 06:30 PM Abstract 085 - Mir-301a Regulation of the Development of a Th17 Response Controls Autoimmune Demyelination
02:00 PM - 06:30 PM Abstract 086 - NKG2 Receptors Acquired by Activated Human CD4 T Cells Are Involved in Oligodendrocyte Destruction in the Context of MS
02:00 PM - 06:30 PM Abstract 087 - Specificity and Potential Pathogenicity of Antibodies to a Central Nervous System (CNS) Autoantigen in Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 088 - Search for Nodal and Paranodal Autoantibodies in Patients with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 089 - Neurons Regulate Glial Cell Surface Proteome
02:00 PM - 06:30 PM Abstract 090 - Astrocytes Secrete Bridging Molecules That May Be Responsible for Increased Microglial Uptake of Apoptotic Inflammatory Cells
02:00 PM - 06:30 PM Abstract 091 - Neurotrophin Peptidomimetics Activate TrkA/B Signaling and Display Neuroprotective Effects in Neuroinflammation and Neurodegeneration
02:00 PM - 06:30 PM Abstract 092 - Human Mesenchymal Stem Cells (MSC) Reciprocally Modulate Th1 and Th17 Responses: Role for PGE2
02:00 PM - 06:30 PM Abstract 093 - Innate Immunity Mediated Model of Primary Oligodendrogliopathy
02:00 PM - 06:30 PM Abstract 094 - Multiple Sclerosis Patients Taking Disease Modifying Treatments Endorse Less Severe Symptoms and Improved Quality of Life Compared with Patients Not on Treatment
02:00 PM - 06:30 PM Abstract 095 - Structural Equation Modeling for Interventions To Improve Quality of Life in Patients with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 096 - Health-Related Quality of Life Is Reduced in Multiple Sclerosis Patients Whose Walking Speed Declines over Time
02:00 PM - 06:30 PM Abstract 097 - Relationship between Timed 25-Foot Walk Walking Speed and Health-Related Quality of Life in AFFIRM and SENTINEL
02:00 PM - 06:30 PM Abstract 098 - Daclizumab HYP Monotherapy Improved Health-Related Quality of Life Parameters in Relapsing-Remitting Multiple Sclerosis: Findings of the SELECT Trial
02:00 PM - 06:30 PM Abstract 099 - Evaluation of the Quality of Life of Patients Affected by Multiple Sclerosis According to Their Own Perception and the Perception of Their Relatives
02:00 PM - 06:30 PM Abstract 100 - Does Change in Patient-Reported QOL Correlate with Change in Other Clinical and MRI Measures in Early MS? Analysis of the 10-Year CHAMPIONS Cohort
02:00 PM - 06:30 PM Abstract 102 - Effects of BG-12 on Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis: Findings from the DEFINE Study
02:00 PM - 06:30 PM Abstract 103 - Examining Predictors of the Physical and Mental Components of Quality of Life in the TOP MS Study
02:00 PM - 06:30 PM Abstract 104 - Interim Analysis of a Randomized Placebo-Controlled Pilot Trial of Armodafinil for Fatigue in Patients with Malignant Gliomas Undergoing Radiotherapy with or without Standard Chemotherapy Treatment
02:00 PM - 06:30 PM Abstract 105 - Frequency of Gastrointestinal Problems in Neurofibromatosis Type 1: The Johns Hopkins Experience
02:00 PM - 06:30 PM Abstract 106 - Frequency of the Metabolic Syndrome and Association with Survival in Newly Diagnosed GBM Patients: A Retrospective Review
02:00 PM - 06:30 PM Abstract 107 - Reasons To Visit the Neurologist in Patients with Systemic Cancer
02:00 PM - 06:30 PM Abstract 108 - Primary Brain and Central Nervous System Neoplasms in the Automated Central Tumor Registry: 2000-2010
02:00 PM - 06:30 PM Abstract 109 - Recursive Partitioning Analysis Identifies Prognostic Groups for Glioblastoma Patients Aged 70 Years or Older
02:00 PM - 06:30 PM Abstract 110 - Patterns of Care of Elderly Patients with Glioblastoma: Resource Implications from a Population-Based Study
02:00 PM - 06:30 PM Abstract 111 - Elevated Preoperative Glucose Levels and Survival in Elderly Newly Diagnosed Glioblastoma Patients
02:00 PM - 06:30 PM Abstract 112 - Outcomes of Hospitalization in Pregnant Women with Brain Tumors: A Population-Based Study
02:00 PM - 06:30 PM Abstract 113 - Systematic Review of CNS Metastasis in Patients with Breast Cancer
02:00 PM - 06:30 PM Abstract 114 - Human Immunodeficiency Virus Infection and Status Epilepticus in United States (2002-2009)
02:00 PM - 06:30 PM Abstract 115 - Age-Sex, Comorbidities, and Health Care Utilization of Individuals with Epilepsy Insured by Multiple U.S. Commercial Health Insurance Plans - A Descriptive Study
02:00 PM - 06:30 PM Abstract 116 - Quality Indicators for Epilepsy Care in Zambia: Roadwork for the WHO Mental Health Gap Action Programme (mhGAP) Guidelines
02:00 PM - 06:30 PM Abstract 117 - Mortality in People with Epilepsy: A Prospective Study in a Prevalent Epilepsy Cohort in South India
02:00 PM - 06:30 PM Abstract 118 - Taking the Clinic to the Patient - Glimpses of Epilepsy Care by the Lifeline Express in Rural India
02:00 PM - 06:30 PM Abstract 119 - Prevalence and Risk Factors of Seizures Following Ischemic Stroke in Patients with Chagas Disease
02:00 PM - 06:30 PM Abstract 120 - Early Electroencephalography (EEG) in Patients with New-Onset Seizures: Diagnostic Yield and Impact on Clinical Decision-Making
02:00 PM - 06:30 PM Abstract 122 - Rates of Psychiatric and Medical Comorbidity in Patients with Seizure Disorder: Evidence from an Electronic Database
02:00 PM - 06:30 PM Abstract 123 - Change in Prevalence of Chronic Conditions over a Period of 14 Years in Patients with Epilepsy
02:00 PM - 06:30 PM Abstract 124 - Prevalence of Neurodegenerative Parkinsonism in the Isolated Population of South-Eastern Moravia, Czech Republic
02:00 PM - 06:30 PM Abstract 125 - Diabetes Is Associated with Bradykinesia and Postural Instability and Gait Difficulty in Parkinson Disease Independent of Nigrostriatal Dopaminergic Denervation: A Case-Control Study
02:00 PM - 06:30 PM Abstract 126 - The Impact of MRI White Matter Hyperintensities on the Dementia in Parkinson's Disease in Relation to the Homocysteine Level and Other Vascular Risk Factors
02:00 PM - 06:30 PM Abstract 127 - Associations of Welding and Manganese Exposure with Parkinson's Disease: A Systematic Review and Meta-Analysis
02:00 PM - 06:30 PM Abstract 128 - Excessive Daytime Sleepiness and Neuron Loss in the Locus Coeruleus: The Honolulu-Asia Aging Study
02:00 PM - 06:30 PM Abstract 129 - The Prevalence of Impaired Olfaction in Parkinson's Disease Is Higher Than Previously Estimated
02:00 PM - 06:30 PM Abstract 130 - Prevalence Estimates of Parkinson Disease among American Indian and Alaska Native People
02:00 PM - 06:30 PM Abstract 131 - Early-Adult Life Correlates of Personality in Parkinson's Disease
02:00 PM - 06:30 PM Abstract 132 - Premorbid Personality and the Risk of Parkinson's Disease
02:00 PM - 06:30 PM Abstract 133 - Occupational Characteristics and Patterns as Risk Factors for Parkinson's Disease
02:00 PM - 06:30 PM Abstract 134 - Head Injury and Parkinson's Disease
02:00 PM - 06:30 PM Abstract 135 - NINDS Funding: Are Children (and Child Neurologists) Getting Their Share?
02:00 PM - 06:30 PM Abstract 136 - Trends in Outcomes and Hospitalization Charges among Non Mechanically Ventilated Pediatric Patients with Status Epilepticus in the United States (1994-2009)
02:00 PM - 06:30 PM Abstract 137 - Intrauterine Nicotine Exposure, Birth Weight, Gestational Age and the Risk of Infantile Colic. Does Central Nervous System Development Play a Role in Infantile Colic?
02:00 PM - 06:30 PM Abstract 138 - Prevalence and Patterns of Developmental Delay in Multiple Gestation Preterm Infants
02:00 PM - 06:30 PM Abstract 139 - Anti - N-Methyl-D-Aspartate (NMDA) Receptor Antibody Encephalitis: A Case Series of Pediatric Patients
02:00 PM - 06:30 PM Abstract 140 - Anti-NMDA Receptor Encephalitis in Children Is Associated with Variable Outcome
02:00 PM - 06:30 PM Abstract 141 - Syringomyelia in Neurofibromatosis Type 1: True Association or Incidental Finding?
02:00 PM - 06:30 PM Abstract 142 - Childhood ADHD Diagnosis, Behaviors, and Motor Overflow Correlate with Slower Inter-Hemispheric Inhibitory Signaling as Measured with Transcranial Magnetic Stimulation
02:00 PM - 06:30 PM Abstract 143 - Quantification of Dysrhythmia in Children with ADHD Using a Novel Automated Goniometer Method
02:00 PM - 06:30 PM Abstract 144 - Children with ADHD Show Increased Variability in Sequential Finger Movements
02:00 PM - 06:30 PM Abstract 145 - Increased Cortical Excitability: A Mechanism for Alcohol Withdrawal Symptoms?
02:00 PM - 06:30 PM Abstract 146 - Oculofaciopalatal and Lingual Myoclonus with Two Separate Generators Following Brainstem Stroke
02:00 PM - 06:30 PM Abstract 147 - Evolving Sjogren to POEMS Neuropathy Associated with a Large B-Cell Lymphoma: A Case Report
02:00 PM - 06:30 PM Abstract 148 - Maternally Inherited Diabetes and Deafness (MIDD) Syndrome Associated with Myoclonus
02:00 PM - 06:30 PM Abstract 149 - Painful Lumbosacral Plexopathy Resulting from Perineural Metastasis of Primary Squamous Cell Penile Carcinoma: A Case Report
02:00 PM - 06:30 PM Abstract 150 - An Unusual Cause of Left Hemiplegia in a Renal Transplant Patient
02:00 PM - 06:30 PM Abstract 151 - Clinical and Electrophysiologic Characterization of Chronic and Critical Ischemic Monomelic Neuropathy after Revascularization: A Case Series
02:00 PM - 06:30 PM Abstract 152 - Brainstem Strokes in a Pediatric Patient with Polyarteritis Nodosa: A Unique Case of CNS Vasculitis
02:00 PM - 06:30 PM Abstract 153 - Body Temperature and Lactic Acid Level as Prognostic Factors in Hypoglycemic Coma
02:00 PM - 06:30 PM Abstract 154 - Neurosarcoidosis Revealed by Isolated Abducens Nerve Palsy
02:00 PM - 06:30 PM Abstract 155 - Does Progression and Mortality in Mild Cognitive Impairment Vary in Men and Women? The Mayo Clinic Study of Aging
02:00 PM - 06:30 PM Abstract 156 - Proactive Dementia Care: A Five-Year Experience in Dementia Caregiver Counseling
02:00 PM - 06:30 PM Abstract 157 - Medical Costs along the Trajectory of Cognitive Decline in the Elderly: A Population-Based Study
02:00 PM - 06:30 PM Abstract 158 - The Relationship of Insulin Resistance with Cognitive Dysfunction Domain in Non-Diabetic MCI and AD Patients
02:00 PM - 06:30 PM Abstract 159 - Estrogen Receptor [beta] Variants Modify Risk for Alzheimer's Disease in a Multiethnic Female Cohort
02:00 PM - 06:30 PM Abstract 160 - Multidimensional Complexity in the Dementias: Diagnosis, Stage, Comorbidity, and Neuropsychiatric Symptoms
02:00 PM - 06:30 PM Abstract 161 - Early-Life Sexual and Physical Abuse and Self-Perceived Cognitive Impairment in Mid-Adulthood
02:00 PM - 06:30 PM Abstract 162 - Executive Dysfunction Precedes Memory Decline and Is Related to Increased Stress in Preclinical MCI
02:00 PM - 06:30 PM Abstract 163 - Orange County Vital Aging Program: A Community-Based Approach To Reduce Impact of Alzheimer's Disease on Health Care Resources
02:00 PM - 06:30 PM Abstract 164 - Survey Cross-Sectional Prevalence Study of Dementia and Mild Cognitive Impairment. Pilot Study (Phase 1)
02:00 PM - 06:30 PM Abstract 165 - The Prodromal Phase of Frontotemporal Lobar Degeneration: Mild Cognitive Impairment of the FTLD Type
02:00 PM - 06:30 PM Abstract 166 - Behavioral Profiles Differ in Corticobasal Syndrome (CBS) and Behavioral Variant Frontotemporal Dementia (bvFTD)
02:00 PM - 06:30 PM Abstract 167 - Primary Progressive Apraxia of Speech (PAS): A Distinct Neurodegenerative Syndrome
02:00 PM - 06:30 PM Abstract 168 - Handedness in FTLD
02:00 PM - 06:30 PM Abstract 169 - Neural Correlates of Repetitive/Aberrant Motor Behaviors in Behavioral Variant Frontotemporal Dementia (bvFTD)
02:00 PM - 06:30 PM Abstract 170 - Neuropsychiatric Inventory Profile in Frontal Dementias
02:00 PM - 06:30 PM Abstract 171 - Nonfluent/Agrammatic Variant of PPA with a PIB Positive PET Scan and Pick's Disease Pathology
02:00 PM - 06:30 PM Abstract 172 - Clinical, Neuroimaging, and Pathologic Features in a Group of Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Studied Prospectively
02:00 PM - 06:30 PM Abstract 173 - Personality in Frontotemporal Dementia
02:00 PM - 06:30 PM Abstract 174 - Coordination Limitations in Behavioral Variant Frontotemporal Dementia Have Consequences for Communication
02:00 PM - 06:30 PM Abstract 175 - Rodent Model of the Effect of beta-Adrenergic Agents on Creative Problem Solving
02:00 PM - 06:30 PM Abstract 176 - Enhancement of Extinction Memory and Prefrontal Cortex Metabolic Capacity Via Low-Level Light Therapy
02:00 PM - 06:30 PM Abstract 177 - Cortical Deafness: A Case of Selective Auditory Agnosia, Amusia and Word Deafness
02:00 PM - 06:30 PM Abstract 178 - Hand Preference in Developmental Stuttering: A Test of the Geschwind-Galaburda Hypothesis of Hemispheric Specialization
02:00 PM - 06:30 PM Abstract 179 - Effect of Natalizumab on Cognitive Impairments in Relapsing Forms of Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 180 - Comparison of Quality of Life and Disability in Three Different Dementias
02:00 PM - 06:30 PM Abstract 181 - Cognitive and Neuropsychiatric Impairment in the Early Stages of Multiple Sclerosis: Longitudinal Follow-Up in a Latin American Cohort
02:00 PM - 06:30 PM Abstract 184 - Behavioral and Neurostructural Markers of Emotion Recognition Impairment in Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 185 - Theory of Mind and Social Cognition in Huntington's Disease, Clinical Correlations - A Preliminary Report
02:00 PM - 06:30 PM Abstract 186 - Dissociation of Verbal and Spatial Working Memory in the Fronto-Parietal Network
02:00 PM - 06:30 PM Abstract 187 - Disordered Tactile Force Perception in Parkinson's Disease
02:00 PM - 06:30 PM Abstract 188 - Aprosodic Speech and Insular Lesions as Main Features of a Massive Tauopathy in Frontotemporal Dementia
02:00 PM - 06:30 PM Abstract 189 - Parkinsonism-Dementia-ALS Complex (PDA) Phenotype in an African-American Patient
02:00 PM - 06:30 PM Abstract 190 - Severe Anxiety and Frontal Cognitive Dysfunction Heralding a Progressive Supranuclear Palsy-Corticobasal Overlap Syndrome
02:00 PM - 06:30 PM Abstract 191 - Cerebrovascular Diseases Complicating Ventriculoperitoneal Shunt Response in Secondary Normal Pressure Hydrocephalus
02:00 PM - 06:30 PM Abstract 192 - Comparison of Cognitive Functioning in Patients with Parkinson Disease and Frontotemporal Dementia Behavioral Variant
02:00 PM - 06:30 PM Abstract 193 - Different Kinds of Impulsivity in Patients with Behavioral Variant Frontotemporal Dementia (bvFTD)
02:00 PM - 06:30 PM Abstract 194 - The Utility of the INECO Frontal Screening (IFS) in the Detection of Executive Dysfunction in Patients with Traumatic Brain Injury (TBI)
02:00 PM - 06:30 PM Abstract 195 - A Neurotrypsin Resistant Agrin Fragment (NT-1654) Reverts Both Impaired Performance and Muscle Pathology in Transgenic Mice Modelling Sarcopenia
02:00 PM - 06:30 PM Abstract 196 - Thigh Muscle Mass Decline Was Associated Brain Small Vessel Diseases in Men; Possible Link between Sarcopenia and Dementia
02:00 PM - 06:30 PM Abstract 197 - Evaluation of Muscle Atrophy: Comparison between Limb-Girdle Muscular Dystrophies, ALS and Metabolic Myopathies
02:00 PM - 06:30 PM Abstract 199 - Nerve-Stimulation-Induced Near-Infrared Optical Signals Distinguish Diabetic Muscles from Healthy Muscles
02:00 PM - 06:30 PM Abstract 200 - Phosphoglucomutase (PGM 1) Deficiency: A Novel Defect of Muscle Glycogen Degradation and Synthesis
02:00 PM - 06:30 PM Abstract 201 - McArdle Disease: Clinical Features, Muscle Biopsy and Molecular Genetics in Brazilian Patients
02:00 PM - 06:30 PM Abstract 202 - Lack of Myopathologic Changes in Clinically Unaffected Muscles in Patients with Late-Onset Pompe's Disease
02:00 PM - 06:30 PM Abstract 203 - Core-Rod Myopathy Is a Genetically Heterogeneous Condition: Clinical and Morphological Analysis of a Cohort of Patients without Molecular Characterization
02:00 PM - 06:30 PM Abstract 204 - Neuromuscular Involvement in Choreoacanthocytosis
02:00 PM - 06:30 PM Abstract 205 - PEO1 Gene (Twinkle) Mutation and Multi-Organ Failure Following Propofol Infusion
02:00 PM - 06:30 PM Abstract 206 - POLG-Related Disorders: Muscle Biopsy Findings, Mitochondrial DNA Content and Deletions
02:00 PM - 06:30 PM Abstract 207 - POLG Mutation in a Patient with Cataracts, Early-Onset Distal Muscle Weakness and Atrophy and Ovarian Dysgenesis
02:00 PM - 06:30 PM Abstract 208 - The Molecular Etiology of Progressive External Ophthalmoplegia (PEO) Associated with Mitochondrial Myopathy
02:00 PM - 06:30 PM Abstract 209 - MERRF and Kearns-Sayre Overlap Syndrome Due to the Mitochondrial DNA M.3291T>C Mutation
02:00 PM - 06:30 PM Abstract 210 - Novel ND-5 Mutation in a Patient with Kearns-Sayre Syndrome Phenotype
02:00 PM - 06:30 PM Abstract 211 - Nitric Oxide Synthesis and Apoptosis in Cells with Mitochondrial Abnormalities
02:00 PM - 06:30 PM Abstract 212 - Development of Optimized Assays for Mitochondrial Respiratory Chain Enzymatic Activities in Muscle and Cells
02:00 PM - 06:30 PM Abstract 213 - Quantitative Analysis of Supercomplexes Using Coomassie-Stained Blue Native Gels
02:00 PM - 06:30 PM Abstract 214 - Comprehensive Mitochondrial Haplogroup Analysis System Based on Suspension-Array Technology Using DNA from Formalin-Fixed Paraffin-Embedded Autopsy Tissues
02:00 PM - 06:30 PM Abstract 215 - Molecular Diagnostic Approaches to Metabolic Myopathies by Target Gene Capture and Next Generation Sequencing
02:00 PM - 06:30 PM Abstract 216 - Rates of Adverse Events after High Dose IVIG Infusions Do Not Differ among Patients Receiving 2-Day Versus 5-Day Infusions
02:00 PM - 06:30 PM Abstract 217 - Successful Use of Subcutaneous Immunoglobulin in Chronic Neurology Patients
02:00 PM - 06:30 PM Abstract 218 - CNS Disease as the Presenting Feature in Four Cases of Juvenile Dermatomyositis
02:00 PM - 06:30 PM Abstract 219 - A Retrospective Analysis of a Treatment Protocol of Juvenile Dermatomyositis with Intravenous Methylprednisolone, Intravenous Immunoglobulin, and Methotrexate
02:00 PM - 06:30 PM Abstract 220 - Anti-Synthetase Syndrome: An Under-Recognized Entity
02:00 PM - 06:30 PM Abstract 221 - Clinical and Diagnostic Variability of Inclusion Body Myositis
02:00 PM - 06:30 PM Abstract 222 - Restrictive Ventilatory Defect in Patients with Inclusion Body Myositis
02:00 PM - 06:30 PM Abstract 223 - Is a Muscle Biopsy Necessary for the Diagnosis of Inclusion Body Myositis (IBM)?
02:00 PM - 06:30 PM Abstract 224 - The Effect of Anakinra, an IL-1 Receptor Antagonist, in Patients with Inclusion Body Myositis (sIBM): A Small Pilot Study
02:00 PM - 06:30 PM Abstract 225 - Twelve-Month Change of IBMFRS in the Arimocolomol Inclusion Body Myositis Pilot Study
02:00 PM - 06:30 PM Abstract 226 - Readability of Online Patient 好色先生 Materials for Peripheral Neuropathy
02:00 PM - 06:30 PM Abstract 227 - A Qualitative Characterization of Mentorship in Vascular Neurology
02:00 PM - 06:30 PM Abstract 228 - Simulation Based Training for Acute Stroke Alerts
02:00 PM - 06:30 PM Abstract 229 - Age-Related Memory Loss and Alzheimer's Disease: A Randomized, Web-Based 好色先生al Intervention Study
02:00 PM - 06:30 PM Abstract 230 - Novel Simulation Lab Exercises for Training Neurology Residents How To Manage Acute Stroke
02:00 PM - 06:30 PM Abstract 231 - A Novel Web Based Modified Rankin Scale Program for Certification and Patient Self Assessment Scoring in the Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH II) Trial
02:00 PM - 06:30 PM Abstract 232 - Web-Based Neuro-Ophthalmic Patient 好色先生
02:00 PM - 06:30 PM Abstract 233 - Residents as Teachers: Disconnect between Faculty and Self Assessment of Skills
02:00 PM - 06:30 PM Abstract 234 - The Clinical Skills Examination Training Program (CSET): An Interactive Training Exercise for Evaluators
02:00 PM - 06:30 PM Abstract 235 - Low-Cost Diagnostic Gaming To Measure Symptom-Specific Diagnostic Reasoning Skills
02:00 PM - 06:30 PM Abstract 236 - Retention of Lumbar Puncture Skills Gained by a Mastery Learning Approach Using Simulation Technology and Deliberate Practice
02:00 PM - 06:30 PM Abstract 237 - Assessment of Handover Communication among Neurology Residents: Utilization of a Handover OSCE and a Standardized Curriculum To Improve Transitions of Care
02:00 PM - 06:30 PM Abstract 238 - Measuring Handover Communication during Transition of Care from the Neurointensive Care Unit to the General Neurology Ward
02:00 PM - 06:30 PM Abstract 239 - Medication Events on a Tertiary Neurology Inpatient Service
02:00 PM - 06:30 PM Abstract 240 - Application of Team-Based Learning To Teach Neurology Residents
02:00 PM - 06:30 PM Abstract 241 - E-Learning Preferences of European Junior Neurologists
02:00 PM - 06:30 PM Abstract 242 - A Neurophysiology OSCE as a Marker for Performance on the Resident in Training Examination
02:00 PM - 06:30 PM Abstract 243 - On-Call Shifts during Neurology Residency in a Spanish Tertiary Academic Hospital: A Quantitative Analysis
02:00 PM - 06:30 PM Abstract 244 - The Use of Seizure Videos in Educating Medical Students in Differentiating Non-Epileptic Seizures (Motor Events) from Epileptic Seizures
02:00 PM - 06:30 PM Abstract 245 - Daily Written Reflections Improve Medical Student Learning during a Third-Year Child Neurology Rotation
02:00 PM - 06:30 PM Abstract 246 - Neurophobia in Medical Students and Junior Doctors in Singapore - Blame the GIK
02:00 PM - 06:30 PM Abstract 247 - Video Gaming: A Pilot Study Tool To Enhance Localization in Neurology
02:00 PM - 06:30 PM Abstract 248 - Feasibility of a Simple Audience Response System Using SMS Messaging
02:00 PM - 06:30 PM Abstract 249 - Role of MR Imaging in the Diagnosis of Idiopathic Intracranial Hypertension: A Prospective Study from a Tertiary Teaching Hospital of South India
02:00 PM - 06:30 PM Abstract 250 - Sympathetic Neurotransmission Increases Local TGF-beta-2 in the Eye and Supports Ocular Inflammation
02:00 PM - 06:30 PM Abstract 251 - Relapsing Inflammatory Optic Neuropathy: A Multicenter Study of 62 Patients
02:00 PM - 06:30 PM Abstract 253 - Inpatient and Emergency Services Utilization in Idiopathic Intracranial Hypertension
02:00 PM - 06:30 PM Abstract 254 - Optic Nerve Imaging Using Synchrotron Radiation
02:00 PM - 06:30 PM Abstract 255 - Phase IV Vision Study Evaluates Retinal Structure and Function in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin
02:00 PM - 06:30 PM Abstract 256 - A Case of Terson's Syndrome Status-Post High Volume Lumbar Puncture
02:00 PM - 06:30 PM Abstract 257 - Delayed Onset of Papilledema in Cerebral Venous Sinus Thrombosis (CVST)
02:00 PM - 06:30 PM Abstract 258 - Secondary Invasion of the Optic Nerve Head by a Frontal Lobe Anaplastic Astrocytoma
02:00 PM - 06:30 PM Abstract 259 - Deriving Clinically Useful Visual Evoked Potential Measurements from 120 Sector Multi-Focal Visual Evoked Potential Sequences
02:00 PM - 06:30 PM Abstract 260 - Visual Evoked Potential Latency Prolongation in MS: Correlation with Cognitive Performance on a Computerized Testing Battery
02:00 PM - 06:30 PM Abstract 261 - Obstructive Sleep Apnea in Idiopathic Intracranial Hypertension: Comparison with Matched Population Data
02:00 PM - 06:30 PM Abstract 262 - Photographic Assessment of Optic Disc and Retinal Vasculature in Obstructive Sleep Apnea (OSA) Patients
02:00 PM - 06:30 PM Abstract 263 - Does Bilateral Transverse Cerebral Venous Sinus Stenosis (TSS) Really Exist in Patients without Increased Intracranial Pressure (ICP)?
02:00 PM - 06:30 PM Abstract 264 - Non-Mydriatic Ocular Fundus Photography Read by Emergency Department (ED) Physicians: FOTO-ED Study
02:00 PM - 06:30 PM Abstract 265 - White and Gray Matter Damage Extends beyond the Visual Pathways in Patients with Autosomal Dominant Optic Atrophy and OPA1 Mutations
02:00 PM - 06:30 PM Abstract 266 - Does the Presence of Transverse Sinus Stenosis (TSS) Influence the Clinical Presentation and Outcome of Idiopathic Intracranial Hypertension (IIH)
02:00 PM - 06:30 PM Abstract 267 - MRI Findings in Idiopathic Intracranial Hypertension (IIH) Compared with Cerebral Venous Thrombosis (CVT)
02:00 PM - 06:30 PM Abstract 268 - Cross Sectional Survey of Visual Acuity and Self-Reported Visual Function in Patients with Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 269 - Long-Term Efficacy and Tolerability of Milnacipran: 3-Year Results from an Open-Label, Flexible-Dosing Study in Patients with Fibromyalgia
02:00 PM - 06:30 PM Abstract 270 - Efficacy of Milnacipran Following Long-Term Treatment of Fibromyalgia: Results from a Randomized, Double-Blind, Placebo-Controlled Discontinuation Study
02:00 PM - 06:30 PM Abstract 271 - Effects of Switching from Duloxetine to Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Study in Fibromyalgia
02:00 PM - 06:30 PM Abstract 272 - How To Disclosure the AD Diagnosis to Demented Patients?
02:00 PM - 06:30 PM Abstract 273 - Burning Mouth Syndrome Responsive to Duloxetine: (A Case Report)
02:00 PM - 06:30 PM Abstract 274 - Duty of Care to the Unconscious Patient - Approaching the Controversies of the Persistent Vegetative State by Fulfilling the Physician's Duty of Care
02:00 PM - 06:30 PM Abstract 275 - Encephalocele: The Dilemma of When To Surgically Intervene
05:00 PM - 06:30 PM Break
Faculty Disclosures
Gregory W. Albers, MD No disclosure on file
Vladimir Hachinski, MD, DSc, FAAN Dr. Hachinski has nothing to disclose.
No disclosure on file
Brian G. Weinshenker, MD, FAAN Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zenas Pharma. Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care.
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Bradford Dickerson, MD, FAAN Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Samuel A. Frank, MD, FAAN Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel.
David H. Miller, MD, MBChB, FRCP No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Matthew J. Thurtell, MD Dr. Thurtell has received publishing royalties from a publication relating to health care.
Barney J. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care.
Clifton L. Gooch, MD, FAAN Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
John W. Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Nicolas Collongues, MD Nicolas Collongues, MD has nothing to disclose.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Kevin M. Barrett, MD, FAAN Dr. Barrett has nothing to disclose.
David E. Newman-Toker, MD, PhD, FAAN The institution of Dr. Newman-Toker has received research support from NIH, AHRQ, AHA, Moore Foundation. Dr. Newman-Toker has received intellectual property interests from a discovery or technology relating to health care.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Rakesh Khatri, MD, FAAN Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Alpha insight . Dr. Khatri has received personal compensation in the range of $0-$499 for serving as a Survey consultant with Survey company .
Valerie Biousse, MD Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Lisa M. DeAngelis, MD, FAAN Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
William W. Seeley, MD Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Jerry Lin, BS Mr. Lin has nothing to disclose.
Horacio Senties Madrid No disclosure on file
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
J Mocco No disclosure on file
Erwin Chiquete, MD, PhD No disclosure on file
Fabio M. Iwamoto, MD No disclosure on file
Sandra Vanotti, MD No disclosure on file
Jaishri Blakeley, MD, FAAN Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Stewart H. Mostofsky, MD No disclosure on file
Christopher H. Gibbons, MD, FAAN Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Steven J. Greenberg, MD No disclosure on file
Erle C. Lim, MBBS No disclosure on file
Judith Haas, MD No disclosure on file
Olga Kozlova, MD No disclosure on file
Benny S. Kim, MD Dr. Kim has nothing to disclose.
Linda Magnusson, MD No disclosure on file
Anna Khanna, MD Dr. Khanna has nothing to disclose.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
David Hojnacki, MD, FAAN Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Hajime A. Tokuno, MD Dr. Tokuno has nothing to disclose.
James A. Mortimer, PhD, FAAN No disclosure on file
Roger L. Albin, MD Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex. The institution of Dr. Albin has received research support from NIH-NINDS. The institution of Dr. Albin has received research support from Parkinson's Foundation. The institution of Dr. Albin has received research support from Michael J. Fox Foundation. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as a Grant Application Reivewer with Michael J. Fox Foundation.
Sebina Bulic, MD Dr. Bulic has nothing to disclose.
Simon Faissner Simon Faissner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Simon Faissner has received research support from DMSG. The institution of Simon Faissner has received research support from Novartis. The institution of Simon Faissner has received research support from Lead Discovery.
Ali Saber Tehrani, MD Dr. Saber Tehrani has nothing to disclose.
Bashar Katirji, MD, FAAN Dr. Katirji has nothing to disclose.
Lauren E. Abrey, MD No disclosure on file
Lakshmi Nayak, MD Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curis. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Nayak has received publishing royalties from a publication relating to health care.
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Amy Conger No disclosure on file
Amy M. Duhig, PhD No disclosure on file
Susan W. Law, DO Dr. Law has nothing to disclose.
Harini Sarva, MD, FAAN Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Nicholas Blondin, MD Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Arun Chandok, MD Dr. Chandok has nothing to disclose.
Maya L. Henry, PhD No disclosure on file
Fawaz Al-Mufti, MD Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Omar I. Ahmad, MD No disclosure on file
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Kevin Tan, MD, FAAN Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Chris H. Polman, MD No disclosure on file
Andrea Falini No disclosure on file
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Miri Ben-Ami No disclosure on file
Claude Nguyen, MD Dr. Nguyen has nothing to disclose.
Lucien Rumbach, MD No disclosure on file
Howard Zwibel, MD No disclosure on file
Dawn O. Kleindorfer, MD, FAAN Dr. Kleindorfer has nothing to disclose.
Suda A. Jirasakuldej, MD No disclosure on file
Andrea Pardo, MD The institution of Dr. Pardo has received research support from UCB Biosciences. The institution of Dr. Pardo has received research support from The Patrick G. and Shirley W. Ryan Foundation . The institution of Dr. Pardo has received research support from NINDS- Stroke Trials Network. The institution of Dr. Pardo has received research support from NINDS-I-ACQUIRE. The institution of Dr. Pardo has received research support from NINDS- VIPS-II.
Amtul Farheen, MD, FAAN Dr. Farheen has nothing to disclose.
Cynthia Leibson, PhD No disclosure on file
Amy R. Borenstein, PhD, FAAN No disclosure on file
Sara Khan, MD Dr. Khan has nothing to disclose.
Arun Kachroo, MD, FAAN No disclosure on file
Steve Chung, MD, FAAN The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Prachi Mehndiratta, MD Dr. Mehndiratta has nothing to disclose.
Christian Confavreux, MD No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Rachel A. Di Trapani, MD No disclosure on file
Nidhi Gupta, MD No disclosure on file
Merrikay Oleen-Burkey, PhD No disclosure on file
Teresa Frohman, PA No disclosure on file
Robert C. Sergott, MD Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
David B. Rye, MD, PhD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jesus Lovera, MD Dr. Lovera has nothing to disclose.
Yousef Mohammad, MD No disclosure on file
Jordan J. Elm The institution of Dr. Elm has received research support from NIH.
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Alison Baird, MBBS, PhD, FRACP, MPH The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from Research Foundation of SUNY. Dr. Baird has received intellectual property interests from a discovery or technology relating to health care. Dr. Baird has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Maimonides Medical Center.
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Arun Krishnan, MD Dr. Krishnan has nothing to disclose.
James Potts No disclosure on file
James R. Perry, MD, FRCP(C), FAAN The institution of Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enveric Biosciences . The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Canadian Brain Tumour Consortium. Dr. Perry has stock in Synaptive Medical.
Christopher Dardis, MD No disclosure on file
Ariel Antezana, MD Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Ayelet Reshef No disclosure on file
Kapil Arya, MBBS, DA, FAAP, FACNS, FAAN Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Arya has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock.
Peter Kanovsky No disclosure on file
Swaroop Pawar, MD Dr. Pawar has nothing to disclose.
Mark Gilbert, MD No disclosure on file
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Stephen M. Davis, MD, FRACP, FAAN No disclosure on file
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Bryan D. Riggeal, MD No disclosure on file
David Ezpeleta No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
R E. Faught, Jr., MD, FAAN Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Ruthanna Hunter, MD No disclosure on file
David Wolf, MD, PhD Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for private law firms.
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Douglas P. Larsen, MD Dr. Larsen has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Board of Medical Examiners.
Daniel Kremens, MD, JD, FAAN Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Neurocrine. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Kremens has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Teva. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Kremens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Kremens has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for UCB.
Numthip Chitravas, MD No disclosure on file
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
David V. Lardizabal, MD, FAAN Dr. Lardizabal has nothing to disclose.
Amit Saindane No disclosure on file
Celedonio Marquez, MD No disclosure on file
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Brigitte Wildemann, MD The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand.
Ioanna Milidou No disclosure on file
Frank Skidmore, MD No disclosure on file
Robert D. Abbott, PhD No disclosure on file
Pablo Mir, MD Dr. Mir has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie, Abbott, Allergan, Bial, Merz, UCB, and Zambon. The institution of Dr. Mir has received research support from Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación) and by Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526, CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, and the Fundación Mutua Madrileña..
Hakan AY, MD Dr. AY has received personal compensation for serving as an employee of Takeda.
Laurel J. Cherian, MD, FAAN The institution of Dr. Cherian has received research support from NIH.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Rana K. Zabad, MD, FAAN Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Kimberley M. Thacker, MD No disclosure on file
Corrado Angelini, MD, FAAN Dr. Angelini has nothing to disclose.
David E. Riley, MD Dr. Riley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with 好色先生. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Ramadevi Gourineni, MD No disclosure on file
Brent A. Burroughs, MD No disclosure on file
Themistokles Kalamatas No disclosure on file
Pablo Lopez, MD No disclosure on file
Brian S. Katz, MD No disclosure on file
Edoardo Malfatti, MD Dr. Malfatti has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark therapeutics. Dr. Malfatti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from Spark Therapeutics. The institution of Dr. Malfatti has received research support from AFM. The institution of Dr. Malfatti has received research support from ANR.
Walter Struhal, MD No disclosure on file
Karen Schreiber, MD No disclosure on file
Felix Schmidt No disclosure on file
Rema Raman, PhD No disclosure on file
Peter S. Pressman, MD Dr. Pressman has received personal compensation in the range of $100,000-$499,999 for serving as a Associate Professor with University of Colorado School of Medicine.
Lutz Harms No disclosure on file
Katya Rascovsky No disclosure on file
Nancy J. Newman, MD, FAAN Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
David J. Capobianco, MD, FAAN No disclosure on file
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
John G. Whitesides John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.
Olivier Godefroy, MD, PhD, FAAN Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NovoNordisk. Prof. Godefroy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ELSEVIER.
Eleanor Orehek, MD No disclosure on file
Rosebud O. Roberts, MD No disclosure on file
Andrew N. Wilner, MD, FACP, FAAN, FAAN Dr. Wilner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS. Dr. Wilner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medscape. Dr. Wilner has received publishing royalties from a publication relating to health care.
Daniel Rosenbaum, MD No disclosure on file
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Katrina Peariso, MD, PhD No disclosure on file
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Brett J. Theeler, MD, FAAN Dr. Theeler has nothing to disclose.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. The institution of Dr. Gilbert has received research support from Quince Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Tyler Fraum No disclosure on file
Gilles Chopard No disclosure on file
Vasileios-Arsenios Lioutas, MD Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Jacques Montplaisir, MD, PhD The institution of Dr. Montplaisir has received research support from CIHR.
Yaacov Anziska, MD Dr. Anziska has nothing to disclose.
Matthew T. Hoerth, MD, FAAN Dr. Hoerth has a non-compensated relationship as a Epilepsy.com Editorial Board member with the Epilepsy Foundation of America that is relevant to AAN interests or activities.
Marc Gotkine, MD No disclosure on file
Vladimir S. Kostic, MD, PhD Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of 好色先生, Science and Technological Development of Serbia.
Ana L. Delgado, MD Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal.
Johann Sellner, MD, FAAN Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Patrick Hecht, PhD Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Styliani (. Marousi No disclosure on file
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Gretchen L. Birbeck, MD, MPH, DTMH, FAAN An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to AAN interests or activities.
Lisa R. Rogers, DO, FAAN Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Jon Currie, MD No disclosure on file
Kamal Masaki, MD No disclosure on file
David J. Libon, PhD No disclosure on file
Tigran Kesayan, MD Dr. Kesayan has nothing to disclose.
Sandro Iannaccone No disclosure on file
Seiji Kikuchi, MD No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Michelle P. Kvalsund, DO Dr. Kvalsund has nothing to disclose.
Lesley M. Arnold, MD No disclosure on file
Ernst-Wilhelm Radue, MD Dr. Radue has nothing to disclose.
Laila K. Jarjour, MB ChB MPH No disclosure on file
Michael G. Hanna, MD, MBBS No disclosure on file
Sushanth Bhat, MD Dr. Bhat has nothing to disclose.
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Facundo Manes No disclosure on file
David S. Silvers, MD, FAAN No disclosure on file
William E. Klunk, MD, PhD No disclosure on file
Helen Petrovitch, MD No disclosure on file
Tae-eun Kim, MD No disclosure on file
Michio Hirano, MD, FAAN Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma SRL. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Communication. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Envision Communications. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for 好色先生. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cure SMA. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Hirano has received research support from UCB. The institution of Dr. Hirano has received research support from Cyclerion. The institution of Dr. Hirano has received research support from Astellas. The institution of Dr. Hirano has received research support from Tisento Therapeutics. The institution of Dr. Hirano has received research support from Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Abliva. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
Pooja Khatri, MD, FAAN The institution of Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bayer. The institution of Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Diamedica. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Julian Benito-Leon No disclosure on file
Johanna A. Helenius, MD, PhD Dr. Helenius has nothing to disclose.
Shin C. Beh, MD, FAAN Dr. Beh has received publishing royalties from a publication relating to health care.
Alexander A. Tarnutzer, MD No disclosure on file
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Pilar Mazzetti Soler, MD No disclosure on file
Vikas Kotagal, MD, FAAN Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Edward J. Atkins, MD No disclosure on file
Kirk A. Frey, MD, PhD No disclosure on file
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Hans H. Shuhaiber, MD The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION .
Nina Dronkers, PhD The institution of Dr. Dronkers has received research support from NIH. Dr. Dronkers has received publishing royalties from a publication relating to health care. Dr. Dronkers has received personal compensation in the range of $0-$499 for serving as a grants reviewer with NIH.
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Saud Sadiq, BS, FAAN Ms. Brewi has nothing to disclose.
Fernando J. Caceres, MD No disclosure on file
Imad T. Jarjour, MD, FAAN No disclosure on file
Dolora R. Wisco, MD Dr. Wisco has nothing to disclose.
Jack P. Antel, MD, FAAN Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to AAN interests or activities.
Masaaki Niino, MD No disclosure on file
Mambakkam R. Sivakumar, MD No disclosure on file
Matthew L. Flaherty, MD Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Jacqueline Palace Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Robert F. Lopez-Alberola, MD Dr. Lopez-Alberola has nothing to disclose.
Stefan Schwarz, MD No disclosure on file
Cristian Falup-Pecurariu, MD, PhD Prof. Falup-Pecurariu has nothing to disclose.
Fatma Zaguia No disclosure on file
Masharip Atadzhanov, MD, PhD, DSc, FRCP, FAAN Dr. Atadzhanov has nothing to disclose.
Don C. Bienfang, MD No disclosure on file
Anders Svenningsson, MD No disclosure on file
Evangelia Sotiriou, MD No disclosure on file
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Jouko I. Isojarvi, MD, PhD No disclosure on file
Heather Moss, MD, PhD, FAAN Dr. Moss has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Verana Health. Dr. Moss has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms. The institution of Dr. Moss has received research support from NIH. The institution of Dr. Moss has received research support from Research to Prevent Blindness. Dr. Moss has received intellectual property interests from a discovery or technology relating to health care. Dr. Moss has received personal compensation in the range of $0-$499 for serving as a grant review panel with National Institutes of Health. Dr. Moss has a non-compensated relationship as a Board of Directors with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
Ronald G. Haller, MD No disclosure on file
Daniela Perani, MD No disclosure on file
Jacqueline W. Green, MD No disclosure on file
Nicole Schupf, PhD, DrPH No disclosure on file
Roberta J. Seidman, MD Dr. Seidman has nothing to disclose.
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Marie-Germaine Bousser, MD No disclosure on file
Thomas M. Hemmen, MD, PhD Dr. Hemmen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck & Co. Dr. Hemmen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. The institution of Dr. Hemmen has received research support from NIH.
Haitham Dababneh, MD No disclosure on file
Martijn Muller, PhD No disclosure on file
Waldo Guerrero, MD Dr. Guerrero has nothing to disclose.
Karen Medin, DO No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Beau B. Bruce, MD, FAAN Dr. Bruce has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bayer.
Yutaka Nishigaki, MD No disclosure on file
Alain Vighetto No disclosure on file
Brett M. Kissela, MD, MS, FAAN The institution of Dr. Kissela has received research support from NIH/NINDS. Dr. Kissela has a non-compensated relationship as a Board Member with AHA Regional Board that is relevant to AAN interests or activities.
Phyllis C. Zee, MD, PhD Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for World Sleep Society. Dr. Zee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Brain Foundation. An immediate family member of Dr. Zee has stock in Teva. An immediate family member of Dr. Zee has stock in Pfizer. The institution of Dr. Zee has received research support from National Institutes of Health. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Rachel Goldmann Gross, MD No disclosure on file
John M. Pellock, MD No disclosure on file
Carlos Silvado, MD No disclosure on file
Tetsuya Takahashi, PhD No disclosure on file
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
Martin Weber, MD Dr. Weber has nothing to disclose.
Norman Putzki, MD No disclosure on file
Allison Przekop, DO Dr. Przekop has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Przekop has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acadia.
Margaret Bettin, MD Dr. Bettin has nothing to disclose.
Darwin G. Ramirez-Abreu, MD, FAAN Dr. Ramirez-Abreu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Jeannie E. Ransom No disclosure on file
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Timothy Ambrose, MD No disclosure on file
Elizabeth A. Mauricio, MD, FAAN Dr. Mauricio has nothing to disclose.
Michael C. Levin, MD, FAAN Dr. Levin has received personal compensation for serving as an employee of Merck. Dr. Levin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Levin has received research support from CIHR.
Ali Emami, MD No disclosure on file
Walter A. Kukull, PhD, FAAN The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to AAN interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to AAN interests or activities.
Stephen Ashwal, MD, FAAN Dr. Ashwal has received publishing royalties from a publication relating to health care.
Ioanna Chatzi No disclosure on file
Claudia S. Kay, MD Dr. Kay has nothing to disclose.
Nobuya Fujita, MD No disclosure on file
Gail Widener No disclosure on file
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Vicki Shanker, MD, FAAN Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Justine J. Wang, MBBS, FRACP No disclosure on file
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Arun V. Talkad, MD, BA Dr. Talkad has nothing to disclose.
H. C. Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
George W. Petty, MD No disclosure on file
Anitha Rao, MD An immediate family member of Dr. Rao has received personal compensation for serving as an employee of Abbvie. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurovision. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Virtusense. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. An immediate family member of Dr. Rao has stock in Abbvie. Dr. Rao has a non-compensated relationship as a Executive Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Iram Zaman, DO, FAAN Dr. Zaman has nothing to disclose.
Gary Bloomgren, MD, MBA No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Carlos Melcon No disclosure on file
Diane Allen No disclosure on file
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Joseph S. Kass, MD, JD, FAAN Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Dhairyawan Pokalkar, MD, FAAN No disclosure on file
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Eric T. Wong, MD, FAAN Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Yogesh Moradiya, MD No disclosure on file
Andres Rodriguez-Ruiz, MD Dr. Rodriguez-Ruiz has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Rodriguez-Ruiz has stock in Lourbeth LLC.
David N. McCollum, MD No disclosure on file
Andrew H. Chan, MD No disclosure on file
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Abdelmoity, MD Dr. Abdelmoity has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Livanova Inc.. Dr. Abdelmoity has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Livanova. Dr. Abdelmoity has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB Inc.. Dr. Abdelmoity has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich Inc..
Francisco J. Carod-Artal, MD, FAAN Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyers Squip. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merz. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Maysa Ridha, MD No disclosure on file
Maria Luisa Martinez Gines, MD Dr. Martinez Gines has nothing to disclose.
William J. Weiner, MD No disclosure on file
Dolores Mateo Gonzalez No disclosure on file
Jacob S. Elkins, MD No disclosure on file
Brandon M. Minzer No disclosure on file
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from the NIH.
Wondwossen G. Tekle, MD Dr. Tekle has nothing to disclose.
Darrel Conger No disclosure on file
Nigel C. Tan, MBBS No disclosure on file
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Diana Rojas-Soto, MD Dr. Rojas-Soto has nothing to disclose.
W. T. Kimberly, MD, PhD Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
LynnMarie Trotti, MD Dr. Trotti has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Academy of Sleep Medicine. The institution of Dr. Trotti has received research support from NIH. Dr. Trotti has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AASM, CHEST, Medscape, SRS Foundation, PER CME, Haymarket CME. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH. Dr. Trotti has a non-compensated relationship as a Medical advisory board member with Hypersomnia Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with AASM Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with ABSM that is relevant to AAN interests or activities.
Kelly D. Flemming, MD Dr. Flemming has nothing to disclose.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Claire Henchcliffe, MD, PhD, FAAN Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.
Lori D. Noorollah, MD, FAAN Dr. Noorollah has nothing to disclose.
Meredith Snapp, MD No disclosure on file
Sean Lanigar, MD Dr. Lanigar has nothing to disclose.
Jorge C. Kattah, MD, FAAN Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Amir Khan, MD No disclosure on file
Vincenzo Brescia Morra, MD Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Vivek Rai, MD Dr. Rai has nothing to disclose.
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Eghosa Omoregie, MD No disclosure on file
Cindy L. Jadoo, MD No disclosure on file
Volodymyr Vulkanov, MD Dr. Vulkanov has nothing to disclose.
Johanne Personna-Policard, MD No disclosure on file
Clara De Andres, MD No disclosure on file
Dan J. Capampangan, MD, FAAN No disclosure on file
Frederick W. Unverzagt, PhD No disclosure on file
Anne Foundas, MD, FAAN No disclosure on file
Kimiko Domoto-Reilly, MD Dr. Domoto-Reilly has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MedBridge. The institution of Dr. Domoto-Reilly has received research support from Lawson Health Research Institute. The institution of Dr. Domoto-Reilly has received research support from NIH. The institution of Dr. Domoto-Reilly has received research support from Biogen. The institution of Dr. Domoto-Reilly has received research support from Lewy Body Dementia Association. The institution of Dr. Domoto-Reilly has received research support from Garvey Institute for Brain Health Solutions. The institution of Dr. Domoto-Reilly has received research support from Cognition Therapeutics. The institution of Dr. Domoto-Reilly has received research support from Takayama Family.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Andres M. Villa, MD Dr. Villa has nothing to disclose.
Michael A. Vogelbaum, MD, PhD, FACS No disclosure on file
Jennifer Jain, MD, BSc Dr. Jain has nothing to disclose.
Luc Taillandier, MD No disclosure on file
David P. Harris, MD Dr. Harris has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Daniel Woo, MD, FAAN The institution of Dr. Woo has received research support from NIH.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' 好色先生 Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical 好色先生. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research 好色先生 Social Awareness and Training In Neurosciences.
Joseph Hentz No disclosure on file
William R. Shankle, MD, MS No disclosure on file
Andrew D. Martin, MD No disclosure on file
Sashank Prasad, MD Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.
Sharon P. Nations, MD, FAAN No disclosure on file
Juan C. Garcia Monco Carra, MD, FAAN Dr. Garcia Monco Carra has nothing to disclose.
Vikram Jadhav, MD No disclosure on file
Abdul Qavi No disclosure on file
Zachary N. London, MD, FAAN Dr. London has nothing to disclose.
Jeffrey Mock II, PhD No disclosure on file
Irene L. Katzan, MD Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Christina Azevedo, MD, FAAN Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas Biopharma. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Smith, Henning & Berman LLP. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Lauren Mylacraine No disclosure on file
Qin Li Jiang, MD No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Amanda Bergner No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Nicole A. Chiota-McCollum, MD, MEd Dr. Chiota-McCollum has nothing to disclose.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Steven Hass, PhD No disclosure on file
Caroline Tilikete No disclosure on file
Peter R. Bergethon, MD, FAAN No disclosure on file
Per Soelberg Sorensen No disclosure on file
Asif A. Khan, MD No disclosure on file
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Lisa Burkholder No disclosure on file
David N. Franz, MD No disclosure on file
Sonja Potrebic, MD, PhD, FAAN Dr. Potrebic has nothing to disclose.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Rosana H. Scola, MD Dr. Scola has nothing to disclose.
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Tetsuhiko Ikeda, MD No disclosure on file
Julio C. Rojas-Martinez, MD, PhD Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.
Nancy D. Richert, MD, PhD No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Paulo J. Lorenzoni, MD Dr. Lorenzoni has nothing to disclose.
Jennifer T. Kalina, MS No disclosure on file
Michael A. De Georgia, MD Dr. De Georgia has nothing to disclose.
David Michelson, MD Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. The institution of Dr. Michelson has received research support from UCB SA. The institution of Dr. Michelson has received research support from Teva Pharmaceuticals USA. The institution of Dr. Michelson has received research support from PTC Therapeutics, Inc. The institution of Dr. Michelson has received research support from Novartis. The institution of Dr. Michelson has received research support from Biogen, Inc. Dr. Michelson has received publishing royalties from a publication relating to health care.
Lidia Gardner, PhD, EMBA Dr. Gardner has stock in EMD Serono.
Robert J. Ivnik, PhD No disclosure on file
Alejandro Ponz De Tienda, MD No disclosure on file
Carlo Ferrarese, MD, PhD Dr. Ferrarese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. Dr. Ferrarese has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EISAI.
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Amita Singh, MD No disclosure on file
Aki Sato, MD No disclosure on file
Fanglin Zhang, MD, PhD No disclosure on file
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
Norman L. Foster, MD, FAAN No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Genevieve A. Laforet, MD, PhD No disclosure on file
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Benjamin Bly, MD, PhD No disclosure on file
Andreas Kyrozis, MD No disclosure on file
Tokihisa Nagai No disclosure on file
Nicholas M. Absalom, MD No disclosure on file
Steve Wu, MD The institution of Dr. Wu has received research support from Tourette Association of America.
Salim Chahin, MD Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutic . The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
Deepa Malaiyandi, MD Dr. Malaiyandi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Journal Critical Care Clinics.
Paul W. O'Connor, MD No disclosure on file
Pascal Laforet No disclosure on file
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Shelly D. Ozark, MD Dr. Ozark has nothing to disclose.
Andrew J. Westwood, MD, FAAN Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthcare Business Solutions UK. Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda.
Renzo Figari-Jordan, MD, FAAN Dr. Figari-Jordan has nothing to disclose.
Katherine T. Dawson, MD No disclosure on file
J. Douglas Miles, MD, PhD, FAAN Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Bryan P. Jaycox, PharmD No disclosure on file
Shannon Hinson Shannon Hinson has received intellectual property interests from a discovery or technology relating to health care. Shannon Hinson has received intellectual property interests from a discovery or technology relating to health care.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Manikum Moodley, MD, FAAN Dr. Moodley has nothing to disclose.
Karen Anderson No disclosure on file
Jose Luis Etcheverry, MD No disclosure on file
Shafali Jeste, MD, FAAN Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Marcin P. Mycko, MD No disclosure on file
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Neha Dangayach, MD, FAAN Dr. Dangayach has nothing to disclose.
Ana Piera Blabastre No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Shawn Smyth, MD Dr. Smyth has nothing to disclose.
Igor Grant, MD No disclosure on file
Tanzila Kulman, MD No disclosure on file
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Sandra R. Richman, MD No disclosure on file
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Maira Gironi No disclosure on file
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Clotilde Balucani, MD, PhD Dr. Balucani has nothing to disclose.
Jaroslaw Slawek, MD No disclosure on file
Takeo Kuwabara, MD, PhD, FAAN No disclosure on file
Joseph Herbert, MD No disclosure on file
Kessarin Panichpisal, MD No disclosure on file
Ruggero G. Fariello, MD No disclosure on file
Pablo Villoslada, MD, PhD, FAAN Dr. Villoslada has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Villoslada has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telara Therapeutics. Dr. Villoslada has or had stock in Attune Neurosciences.Dr. Villoslada has or had stock in Bionure Therapeutics.Dr. Villoslada has or had stock in Spiral Therapeutics.Dr. Villoslada has or had stock in Adhera Health.Dr. Villoslada has or had stock in Clarity technologies.Dr. Villoslada has or had stock in QMENTA Inc. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from European Commission. The institution of Dr. Villoslada has received research support from Instituto Salud Carlos III. The institution of Dr. Villoslada has received research support from Focused Ultrasound Foundation and ALS Foundation. The institution of Dr. Villoslada has received research support from Caixa Foundation. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care.
Geoffrey A. Donnan, MD, MBBS No disclosure on file
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
Gil D. Rabinovici, MD, FAAN Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Opeolu Adeoye No disclosure on file
Navneet Kumar, MD, MBBS No disclosure on file
Rohit Bhatia, MD, MBBS, DM Dr. Bhatia has nothing to disclose.
Dean K. Naritoku, MD, FAAN No disclosure on file
Marco Spinazzi, MD, PhD No disclosure on file
Mariska Kooijmans-Coutinho, MD, PhD No disclosure on file
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Paul H. Gordon, MD, PhD, FAAN No disclosure on file
Eric T. Lee, DO No disclosure on file
Zachary Miller, MD Dr. Miller has nothing to disclose.
Masatoyo Nishizawa, MD No disclosure on file
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Lori A. Schuh, MD, FAAN No disclosure on file
Amanda L. Witt, MD No disclosure on file
Jagarlapudi M. Murthy, MD, FAAN Dr. Murthy has nothing to disclose.
Miguel J. Lainez, MD, PhD, FAAN No disclosure on file
John Shoffner IV, MD No disclosure on file
Alexander Zubkov, MD, PhD, FAHA No disclosure on file
Eudocia Q. Lee, MD No disclosure on file
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Ashley Boller No disclosure on file
Jennifer E. Fugate, DO Dr. Fugate has nothing to disclose.
Mark Halvorsen, PharmD Dr. Halvorsen has received personal compensation for serving as an employee of Upsher-Smith Laboratories, LLC. Dr. Halvorsen has stock in Pfizer. Dr. Halvorsen has stock in Amgen. Dr. Halvorsen has stock in Stryker.
Patrick Y. Wen, MD, FAAN Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Marc Dinkin, MD Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bush Graziano Rice & Platter, P.A.. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, PC.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Jessica Shields No disclosure on file
Asim Haque, MD No disclosure on file
Rahul Rathakrishnan, BM, MRCP No disclosure on file
Haralambos Alexopoulos No disclosure on file
Marie-Laure Santiago-Raber, PhD No disclosure on file
Tuan Dong-Si, MD No disclosure on file
Joanna S. Fong-Isariyawongse, MD, FAAN Dr. Fong-Isariyawongse has nothing to disclose.
Aaron E. Miller, MD, FAAN Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Mikayel Grigoryan, MD Dr. Grigoryan has nothing to disclose.
Tanya Lin, MD Dr. Lin has nothing to disclose.
Dagmar Amtmann The institution of Dagmar Amtmann has received research support from Zogenix .
Emilia M. Gatto, MD, FAAN Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Glen M. Doniger, PhD No disclosure on file
Kitti Kaiboriboon, MD No disclosure on file
Marytery Fajardo, MD No disclosure on file
Roumen D. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Shreyansh Shah, MD No disclosure on file
Revere P. Kinkel, MD, FAAN Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Borna Bonakdarpour, MD, FAAN Dr. Bonakdarpour has nothing to disclose.
Honglei Chen, MD, PhD, FAAN The institution of Dr. Chen has received research support from NIH, . The institution of Dr. Chen has received research support from DoD. The institution of Dr. Chen has received research support from Parkinson's Foundation. The institution of Dr. Chen has received research support from MSU GE and Gibby vs. Parky project.
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Jason Valerio, MD No disclosure on file
Brian-Fred M. Fitzsimmons, MD No disclosure on file
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Lilyana M. Amezcua, MD, FAAN Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS. The institution of Dr. Amezcua has received research support from Sanofi/Genzyme. The institution of Dr. Amezcua has received research support from Alexion.
Pramod R. Gupta, MD No disclosure on file
Galeno Rojas, MD No disclosure on file
Anabel R. Chade, MD No disclosure on file
Edward Y. Zamrini, MD Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
A. D. Rothner, MD No disclosure on file
Danita Jones, DO, MPH Dr. Jones has nothing to disclose.
Neil Jouvenat II No disclosure on file
Mohamad Chmayssani, MD No disclosure on file
Max J. Hilz, MD, PhD, FAAN Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN Dr. Sheikh has received personal compensation for serving as an employee of Takeda.
Scott R. Bundlie, MD No disclosure on file
Daniel Kantor, MD, FAAN Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities.
Annette R. Zampelli, CRNP No disclosure on file
Michiya Igase, MD No disclosure on file
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Cedric S. Raine, PhD, DSc No disclosure on file
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Man Mohan Mehndiratta, MD, MBBS, FAAN Dr. Mehndiratta has nothing to disclose.
Santosh Kesari, MD, PhD, FAAN Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
David N. Herrmann, MD, FAAN Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Walid Matar, MD No disclosure on file
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Robert E. Hogan, MD Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
Juan G. Ochoa, MD Dr. Ochoa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Compumedics. Dr. Ochoa has stock in EEG Care, LLC. An immediate family member of Dr. Ochoa has stock in EEG Care, LLC.
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Andrew D. Norden, MD No disclosure on file
Lorene M. Nelson, PhD Dr. Nelson has nothing to disclose.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
William D. Freeman, MD, FAAN Dr. Freeman has nothing to disclose.
Richard D. King, MD, PhD, FAAN Dr. King has nothing to disclose.
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Sylvia M. Lucas, MD, PhD No disclosure on file
Shafeeq Ladha, MD Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi. Dr. Ladha has received publishing royalties from a publication relating to health care.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Michael Ko, MD No disclosure on file
Masayuki Ochi No disclosure on file
Samson Mebrahtu, MD No disclosure on file
Timothy G. Lukovits, MD The institution of Dr. Lukovits has received research support from Bayer.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Puja Aggarwal, MD Dr. Aggarwal has nothing to disclose.
Ajit Dhaunchak, PhD No disclosure on file
David H. Margolin, MD, PhD Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Beatriz H. Kiyomoto No disclosure on file
Dusan Stefoski, MD, FAAN No disclosure on file
Gabriel Persi Gabriel Persi has nothing to disclose.
Emmanuelle Le Page Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Bakri Elsheikh, MD, FAAN Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA.
Alberto A. Gabbai, MD No disclosure on file
Osama O. Zaidat, MD, FAAN Dr. Zaidat has nothing to disclose.
Stephan Schmidt, MD No disclosure on file
Partha S. Ghosh, MD, FAAN Dr. Ghosh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ghosh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Celia H. Tengan, MD No disclosure on file
Chiara Costanzi No disclosure on file
Acary S. Oliveira, MD No disclosure on file
Fabiana Ortega No disclosure on file
Yoko Okada, MD No disclosure on file
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Simona Ferioli, MD Dr. Ferioli has nothing to disclose.
Anna D. Hohler, MD, FAAN Dr. Hohler has nothing to disclose.
Khaled Asi, MD No disclosure on file
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Matthew Sakumoto No disclosure on file
Jerold E. Reynolds, PhD, RCP, RRT Dr. Reynolds has nothing to disclose.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Corey Goldsmith, MD, FAAN Dr. Goldsmith has received publishing royalties from a publication relating to health care.
Heidi Woessner, MD No disclosure on file
Xiaojun You, PhD No disclosure on file
Jessica P. Floyd, MD No disclosure on file
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Peter Darlington, PhD No disclosure on file
Swapna L. Putta, MD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jianjun Gao No disclosure on file
Rochelle T. Sweis, DO No disclosure on file
Dhruvil J. Pandya, MD No disclosure on file
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Jose L. Vega, MD, PhD No disclosure on file
Analia Calle Analia Calle has nothing to disclose.
Michael S. Mega, MD, PhD No disclosure on file
Jeffrey W. Britton, MD, FAAN Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Ariel Majjhoo, MD No disclosure on file
Flavia Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Shahram Majidi, MD Dr. Majidi has nothing to disclose.
Arnold A. Brizuela, MD No disclosure on file
Gregoire Morisse, MSc No disclosure on file
Sonalee Agarwal, PhD No disclosure on file
Sokratis Papageorgiou, MD Dr. Papageorgiou has nothing to disclose.
John Papatriantafyllou, MD Dr. Papatriantafyllou has nothing to disclose.
Nestor Galvez-Jimenez, MD Dr. Galvez-Jimenez has nothing to disclose.
Barbara Bumstead, NP Ms. Bumstead has nothing to disclose.
Maria C. Zurru, MD No disclosure on file
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Katsuhiko Kohara, MD No disclosure on file
Richard P. Goddeau, Jr., DO No disclosure on file
Paul S. Fishman, MD, PhD No disclosure on file
Michelle M. Mezei, MD No disclosure on file
George H. Kraft, MD No disclosure on file
Adil Javed, MD, PhD The institution of Dr. Javed has received research support from Genentech Roche .
Ylmar Correa Neto, MD No disclosure on file
Pedro Mancias, MD No disclosure on file
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Radwa Badawy, MD No disclosure on file
Macarena Cabrera Serrano No disclosure on file
Sarah Janicki, MD No disclosure on file
Stefano F. Cappa, MD Dr. Cappa has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elservier. The institution of Dr. Cappa has received research support from Italian Minsitry of Health.
Carmen Paradas Lopez, MD, PhD No disclosure on file
Simon Vogrin No disclosure on file
Dong Hyun Lee No disclosure on file
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Clarimar Borrero-Mejias, MD Dr. Borrero-Mejias has nothing to disclose.
Keerthi Chandrasekaren No disclosure on file
Julie Rowin, MD, FAAN No disclosure on file
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Brett C. Meyer, MD Dr. Meyer has received personal compensation in the range of $0-$499 for serving as a Consultant for Sevaro Health. An immediate family member of Dr. Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi.
Valentina Emmanuele, MD, PhD Dr. Emmanuele has nothing to disclose.
Jeong-Ho Park, MD No disclosure on file
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN Dr. Von Glehn Silva has nothing to disclose.
Laura Herbelin No disclosure on file
Paul S. Aisen, MD No disclosure on file
Frederic Blanc No disclosure on file
Ann Gruber-Baldini No disclosure on file
Sheetal Patel, MD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Gretchen A. Ayer, MS No disclosure on file
Michael J. Turner, PhD No disclosure on file
Santosh B. Murthy, MD Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CarePoint. Dr. Murthy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Kai M. Denski, DO No disclosure on file
Jaya Trivedi, MD, FAAN The institution of Dr. Trivedi has received research support from Avidity.
Tina Chen No disclosure on file
Yanan Wang No disclosure on file
Jean M. Schoenen, MD, PhD No disclosure on file
Jonathan H. Smith, MD Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Wilson C. Cueva, MD Dr. Cueva has nothing to disclose.
Achim Gass, MD Dr. Gass has nothing to disclose.
Brian D. Moseley, MD Dr. Moseley has received personal compensation for serving as an employee of UCB. Dr. Moseley has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Dr. Moseley has or had stock in UCB.
Maria Travasarou, MD No disclosure on file
Lon R. White, MD No disclosure on file
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Pravin George, DO Dr. George has nothing to disclose.
Tae-Kyeong Lee, MD No disclosure on file
April L. McVey, MD No disclosure on file
Klaus-Peter Wandinger, MD No disclosure on file
Volker Limmroth, MD, PhD No disclosure on file
Lindsy N. Williams, MD No disclosure on file
Roberta Messina, MD, PhD Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Allison Wright Willis, MD Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Mark Cohen Mark Cohen has nothing to disclose.
Esther Cubo Delgado, MD, PhD, FAAN Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Cubo Delgado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Cubo Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Cubo Delgado has received research support from Spanish health ministry. The institution of Dr. Cubo Delgado has received research support from European union grant.
Aiden Haghikia, MD Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene.
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Fenna T. Phibbs, MD No disclosure on file
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Rizwan A. Bashir, MD No disclosure on file
Joseph H. Lee, DrPH MPH BS No disclosure on file
Giuseppe Lanzino, MD Dr. Lanzino has nothing to disclose.
Jonathan G. Guterman, MD No disclosure on file
Konrad Schlick, MD, FAAN Dr. Schlick has nothing to disclose.
Tanya Simuni, MD, FAAN Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Roneil Malkani, MD, FAAN Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with AANI. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities.
Carlos Otavio Brandao, MD, PhD No disclosure on file
James M. Gebel, MD No disclosure on file
Yunxia Wang, MD, FAAN Dr. Wang has nothing to disclose.
Agnieszka Ardelt, MD, PhD Dr. Ardelt has nothing to disclose.
Josephine F. Huang, MD Dr. Huang has nothing to disclose.
Web Ross, MD The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Jesus Rivera Navarro No disclosure on file
Michael L. Rosenberg, MD Dr. Rosenberg has nothing to disclose.
Shravan Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Meliana Trinidad-Mas, MD No disclosure on file
Adam D. Slansky, MD No disclosure on file
Lorraine N. Clark, PhD No disclosure on file
Liudmila Lysenko, MD No disclosure on file
Sudhansu Chokroverty, MD, FAAN No disclosure on file
Tanya Stojkovic Tanya Stojkovic has nothing to disclose.
Jane Uyehara-Lock, MD No disclosure on file
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Isabelle Crassard No disclosure on file
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
Massimo Corbo No disclosure on file
Benito P. Damasceno, MD, PhD No disclosure on file
Iris Katharina Penner, PhD The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
John B. Williamson No disclosure on file
Dennis Earle Fortier No disclosure on file
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Jamuna Rajasingham, MD No disclosure on file
Marcus W. Lee, MD No disclosure on file
Andrew R. Pachner, MD No disclosure on file
Masato Kanazawa, MD, FAAN Dr. Kanazawa has nothing to disclose.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Madhuri Behari, MD No disclosure on file
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Amanda LaMarre No disclosure on file
Lee-jun C. Wong, PhD No disclosure on file
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Brendan J. Kelley, MD, FAAN Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai.
Nizar Chahin, MD Dr. Chahin has nothing to disclose.
David B. Clifford, MD, FAAN Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care.
Muhammad Al-Lozi, MD Dr. Al-Lozi has nothing to disclose.
Teri Schreiner, MD, MPH, FAAN The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Sarah M. Roddy, MD No disclosure on file
David Z. Wang, DO, FAHA, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Leonardo Salviati, MD No disclosure on file
Tamar Bacon The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Camilo E. Fadul, MD, FAAN No disclosure on file
Maura Frigo No disclosure on file
Stanford K. Shu, MD No disclosure on file
Prakash R. Paliwal, MD No disclosure on file
Anat Kesler, MD No disclosure on file
Bruce R. Korf, MD Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Pharmaceuticals. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Healx. Dr. Korf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Recursion. Dr. Korf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genome Medical. Dr. Korf has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Infixion. Dr. Korf has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Human Genetics. Dr. Korf has stock in Genome Medical. The institution of Dr. Korf has received research support from NIH. The institution of Dr. Korf has received research support from Department of Defense. The institution of Dr. Korf has received research support from Children's Tumor Foundation. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care. Dr. Korf has received publishing royalties from a publication relating to health care.
Bernardo Cacho Diaz, MD, FAAN Dr. Cacho Diaz has nothing to disclose.
Alona Muzikansky No disclosure on file
Kimberly Umans No disclosure on file
Mohamed Al-Khaled No disclosure on file
Janet Johnson No disclosure on file
Matthew Eccher, MD, AB, FAAN No disclosure on file
Kathleen Alwell No disclosure on file
Janet Benesh, BSMT No disclosure on file
Glen H. Stevens, DO, PhD, FAAN The institution of Dr. Stevens has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Stevens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. The institution of Dr. Stevens has received research support from National Cancer Institute.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Warren Carrigan III, MD No disclosure on file
Ayal Rozenberg, MD No disclosure on file
Radhika Dhamija, MD, FAAN Dr. Dhamija has nothing to disclose.
Christopher R. Newey, DO Dr. Newey has nothing to disclose.
Alexandra Sibley No disclosure on file
Matthew Abramowitz, MD No disclosure on file
Kameshwar Prasad, MD The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Laszlo Sztriha, MD, PhD No disclosure on file
Sven O. Jarius, MD Dr. Jarius has nothing to disclose.
Christine Short No disclosure on file
Elodie Meppiel No disclosure on file
Stuart D. Cook, MD, FAAN No disclosure on file
Agnieszka Gorzkowska No disclosure on file
Deepak S. Nair, MD Dr. Nair has nothing to disclose.
Carmen Bozic, MD No disclosure on file
Guido Cavaletti No disclosure on file
Sanjay Pandey, MD Dr. Pandey has nothing to disclose.
V V. Vedanarayanan, MD, FRCPC Dr. Vedanarayanan has nothing to disclose.
Rajanandini Muralidharan, MD, FAAN Dr. Muralidharan has nothing to disclose.
Fernando Scaglia, MD Dr. Scaglia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Michelle Mielke No disclosure on file
Nicolas Molnarfi No disclosure on file
Cira Fraser No disclosure on file
Hunaid Hasan, MD No disclosure on file
Kiran Patil No disclosure on file
Joseph Benes, MD Dr. Benes has nothing to disclose.
Ranjith K. Polusani, MD, MBBS No disclosure on file
Jan Drappatz, MD Dr. Drappatz has stock in Pfizer. Dr. Drappatz has stock in Vertex. Dr. Drappatz has stock in GSK. The institution of Dr. Drappatz has received research support from Servier. Dr. Drappatz has received publishing royalties from a publication relating to health care.
Lineu C. Werneck, MD No disclosure on file
Thomas W. Weber, MD No disclosure on file
Francisco Gascon Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANOFI. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SANOFI. The institution of Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NOVARTIS. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Francisco Gascon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALMIRALL.
Grainne Quinn, MD No disclosure on file
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Darine Kassar, MD Dr. Kassar has nothing to disclose.
Gaurav Gupta, MD No disclosure on file
Christophe Hotermans, MD, PhD No disclosure on file
Cynthia Gibson-Horn No disclosure on file
Mamta B. Singh, MD, MBBS, DM, FAAN Dr. Singh has nothing to disclose.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Murali Chekuri No disclosure on file
Rezvan Rostami, MD No disclosure on file
Slawomir Budrewicz No disclosure on file
Yitzchok Lederman No disclosure on file
Gabriela Orzuza No disclosure on file
Elizabeth A. Baraban, PhD, MPH The institution of Dr. Baraban has received research support from Boehringer Ingelheim.
Smriti Agarwal, MD No disclosure on file
Rebecca A. Harrison, MD No disclosure on file
Bernhard Hemmer, MD No disclosure on file
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Volker A. Knappertz, MD Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Stanley J. Iyadurai, MD, PhD, FAAN Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Alok Verma No disclosure on file
Puneet Dixit, MD No disclosure on file
Shivam O. Mittal, MD, FAAN Dr. Mittal has nothing to disclose.
Vanessa Arnedo, MPH No disclosure on file
Jennifer A. O'Malley, MD, PhD Dr. O'Malley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for PTC Therapeutics. Dr. O'Malley has stock in Doximity. An immediate family member of Dr. O'Malley has stock in Amazon.
Mir Reza Bekheirnia No disclosure on file
Catherine Dive-Pouletty No disclosure on file
Eytan Raz No disclosure on file
Mirza Omari, MD Dr. Omari has nothing to disclose.
Julien Sein, PhD No disclosure on file
Keyur Patel, MD No disclosure on file
Alfredo Damasceno, MD No disclosure on file
Nancy Collop No disclosure on file
Elisabeth G. Celius, MD Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Celius has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Adam D. Falchook, MD No disclosure on file
Louise E. Allport, PhD, FRACP No disclosure on file
Charles Bernick, MD Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Optina. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Bernick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corium. Dr. Bernick has stock in Aurora. The institution of Dr. Bernick has received research support from UFC. The institution of Dr. Bernick has received research support from Top Rank Promotions. The institution of Dr. Bernick has received research support from Haymon Boxing.
Diego Torres-Russotto, MD, FAAN Dr. Torres-Russotto has received personal compensation for serving as an employee of Movement Disorders Consulting, Inc. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. The institution of Dr. Torres-Russotto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anneal. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for IPSEN. Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Torres-Russotto has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. The institution of Dr. Torres-Russotto has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Your Nest Asset Solutions, LLC. Dr. Torres-Russotto has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Bright Future Asset Solutions, LLC.
Patrik L. Michel, MD The institution of Dr. Michel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Michel has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. The institution of Dr. Michel has received research support from Swiss National Science Foundation; Swiss Heart Foundation.
Jonathan C. Calkwood, MD Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Calkwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bio. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Calkwood has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Calkwood has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Calkwood has received research support from Sanofi. The institution of Dr. Calkwood has received research support from Novartis. The institution of Dr. Calkwood has received research support from Astra Zenica. The institution of Dr. Calkwood has received research support from TG Therapeutics. Dr. Calkwood has a non-compensated relationship as a Board of Trustees with National MS Society that is relevant to AAN interests or activities.
Marta San Luciano, MD, FAAN Dr. San Luciano has received research support from NIH (NINDS). Dr. San Luciano has received research support from Raynor Cerebellum Project.
Declan Chard Declan Chard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Declan Chard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Declan Chard has received research support from MS Society. Declan Chard has received research support from Hoffmann-La Roche. Declan Chard has received research support from International Progressive MS Alliance. Declan Chard has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Declan Chard has a non-compensated relationship as a trustee with MS Trust that is relevant to AAN interests or activities. Declan Chard has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Declan Chard has a non-compensated relationship as a co-supervisor of a clinical fellowship at the National Hospital for Neurology and Neurosurgery, London, with Merck that is relevant to AAN interests or activities.
Michael R. Schoenberg, PhD, ABPP-CN No disclosure on file
Ho Jin Kim, MD Dr. Kim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altos Biologics, AstraZeneca, Biogen, Daewoong Pharmaceutical, Kaigene, Kolon Life Science, MDimune, Roche, and Sanofi. Dr. Kim has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, AstraZeneca, Eisai, GC Pharma, Merck, Mitsubishi Tanabe Pharma, and Roche. Dr. Kim has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal, Journal of Clinical Neurology.
J. T. Greenamyre, MD, PhD The institution of Dr. Greenamyre has received research support from NIH. The institution of Dr. Greenamyre has received research support from Michael J Fox Foundation. The institution of Dr. Greenamyre has received research support from Calico Life Sciences. The institution of Dr. Greenamyre has received research support from Acurex.
Jennifer L. Clarke, MD, MPH The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. The institution of Dr. Clarke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Dr. Clarke has received research support from Agios. The institution of Dr. Clarke has received research support from Servier. The institution of Dr. Clarke has received research support from Merck.
James McNames No disclosure on file
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Hooman Kamel, MD Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Igor J. Koralnik, MD, FAAN Dr. Koralnik has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Investigation. The institution of Dr. Koralnik has received research support from National Institutes of Health. Dr. Koralnik has received publishing royalties from a publication relating to health care.
Frank Bennett, PhD No disclosure on file
Andrew Solomon, MD, FAAN Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Mark J. Gorman, MD, FAAN No disclosure on file
Christina Marciniak, MD No disclosure on file
Robert S. Feldman, MD No disclosure on file
Bernadette Boden-Albala, DrPH Ms. Boden-Albala has received research support from NIH.
Ans Van Der Ploeg The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme . The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Ans Van Der Ploeg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics . The institution of Ans Van Der Ploeg has received research support from Sanofi Genzyme.
Melissa R. Ortega, MD An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Aptitude. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Oncocyte. An immediate family member of Dr. Ortega has received personal compensation for serving as an employee of Total Health Information.
Tanya Fischer, MD, PhD No disclosure on file
Gianfranco Costantino, MD No disclosure on file
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Herbert Schreiber Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis . Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Herbert Schreiber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Carl Bjartmar, MD, PhD No disclosure on file
Joanna Kitley, MD No disclosure on file
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Marc Wonneberger No disclosure on file
Bruce R. Rosen, MD No disclosure on file
Jaya Goyal No disclosure on file
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Hubert Fernandez, DO No disclosure on file
Marc Kamin, MD Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
Martin-Bastida Antonio No disclosure on file
Suleiman Kojan, MD, FAAN No disclosure on file
Lara W. Katzin, MD Dr. Katzin has nothing to disclose.
Daniel H. Selchen, MD Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva.
Ann D. Bass, MD Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Paulo P. Fontoura, MD, PhD, FAAN Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Alan J. Thompson, MD, FRCP, FAAN No disclosure on file
Andreas Lysandropoulos Andreas Lysandropoulos has nothing to disclose.
Tamir S. Ben-Hur, MD, PhD The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadimastem. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sipnose. The institution of Dr. Ben-Hur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenera Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medasense. Dr. Ben-Hur has received stock or an ownership interest from Sipnose. Dr. Ben-Hur has received stock or an ownership interest from Kadimastem. Dr. Ben-Hur has received stock or an ownership interest from MAPI Pharma. Dr. Ben-Hur has received intellectual property interests from a discovery or technology relating to health care.
Stefanie Mueller-Schunk Stefanie Mueller-Schunk has nothing to disclose.
Adam Ziemann, MD, PhD Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie.
Teena Shetty, MD, FAAN Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Paul Frohna, MD, PhD, PharmD No disclosure on file
Cinzia Cordioli, MD Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Courtney S. Casserly, MD, FAAN Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soliris. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen idec. Dr. Casserly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sanofi genzyme. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Dr. Casserly has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Theraputics. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Soliris. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Dr. Casserly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMG Serono. The institution of Dr. Casserly has received research support from Biogen Idec. The institution of Dr. Casserly has received research support from Western Libraries. The institution of Dr. Casserly has received research support from Western University.
Brian Steingo, MD Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. The institution of Dr. Steingo has received research support from Infinity Clinical Research.
Carmen Castrillo-Viguera Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Nils Koch-Henriksen, MD Dr. Koch-Henriksen has nothing to disclose.
Fernando L. Pagan, MD, FAAN Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Björn Tackenberg, MD, FAAN Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Richard McLachlan, MD No disclosure on file
Anna Forsythe No disclosure on file
Peter S. Chin, MD No disclosure on file
Chrstoph Lassek No disclosure on file
Richard B. Dewey, Jr., MD, FAAN Dr. Dewey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Dewey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Dewey has received research support from NINDS.
Thomas Meier, PhD No disclosure on file
Gaston A. Kuperman, PhD No disclosure on file
Michael Lang No disclosure on file
Jimmy A. Schiemann No disclosure on file
Elissa A. Ritt No disclosure on file
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Carla Demuro No disclosure on file
Kristen Johnson, PhD No disclosure on file
Adam Czaplinski, MD No disclosure on file
Kevin O'Connor, FRACP, MB, BCh, BAO No disclosure on file
Lawrence Hewitt, PhD No disclosure on file
Steve Gorny No disclosure on file
Lesley Schofield No disclosure on file
Esther Bui, MD Dr. Bui has received publishing royalties from a publication relating to health care.
Jens Wuerfel, MD Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
David Miller No disclosure on file
Eduardo Paulo Morawski Vianna, PhD No disclosure on file
Ana Cristina W. Dos Santos No disclosure on file
Gustavo Seifer, Prof Gustavo Seifer, Prof has received personal compensation for serving as an employee of Novartis.
Charbel E. Moussa, PhD, MB Dr. Moussa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for KeifeRX LLC. Dr. Moussa has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharmaceuticals Research Industry. Dr. Moussa has received stock or an ownership interest from Orphan Therapeutics. The institution of Dr. Moussa has received research support from NIA. The institution of Dr. Moussa has received research support from Sun Pharmaceuticals Research Industry. The institution of Dr. Moussa has received research support from Alzheimer's Association . Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received intellectual property interests from a discovery or technology relating to health care. Dr. Moussa has received publishing royalties from a publication relating to health care. Dr. Moussa has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with DG Information Technology. Dr. Moussa has received personal compensation in the range of $0-$499 for serving as a Peer Reviews with National Institutes of Health.
Susan A. Eaton, PharmD No disclosure on file
Alaleh Raji, MD No disclosure on file
Tania Kuempfel, MD Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Xiangyi Meng, PhD Dr. Meng has nothing to disclose.
Martin Freed No disclosure on file
Ellen Snyder, MD Dr. Snyder has nothing to disclose.
Kelly Hanley Kelly Hanley has nothing to disclose.
Luca Prosperini, MD No disclosure on file
Neetu Agashivala No disclosure on file
Jorina Elbers, MD No disclosure on file
Lars Komorowski Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Robert Hendricks No disclosure on file
John B. Edwards, MD No disclosure on file
Matthew Klein Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.
Gaelle Klingelschmitt Gaelle Klingelschmitt has received personal compensation for serving as an employee of F.Hoffmann-La Roche LTD.
Andrew Pennell No disclosure on file
Ian Bonzani, PhD No disclosure on file
Gerry Rowse No disclosure on file
Cameron Brennan Cameron Brennan has nothing to disclose.